Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Georgetown University psychologist Andrea Bonior told Fox News Digital she has seen an uptick in patients, many of whom are ...
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...
India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.
The difficulty of securing insurance coverage can impede the therapy process. Armed with advice and templates, a nonprofit is helping patients and providers get what they're due.
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
51m
Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback